Clinical Trials Directory

Trials / Completed

CompletedNCT05143710

The Clinical and Prognostic Features of PRES

The Features of Clinical Imaging, Disease Severity and Pregnancy Outcomes in Posterior Reversible Encephalopathy Syndrome With Preeclampsia or Eclampsia

Status
Completed
Phase
Study type
Observational
Enrollment
354 (actual)
Sponsor
Dunjin Chen · Academic / Other
Sex
Female
Age
16 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the features of clinical imaging, disease severity and pregnancy outcomes in posterior reversible encephalopathy syndrome with preeclampsia or eclampsia.

Detailed description

The investigators retrospectively collected data (General information, clinical data, biochemical indicators, imaging features, and pregnancy outcome) from pregnant woman diagnosed with PRES with preeclampsia or eclampsia to analyze features of clinical imaging, disease severity and pregnancy outcomes during 2012 to 2021.Then, the investigators grouped all the patients into early onset group and late onset PE group according to gestational weeks to analyze differences of clinical imaging. Finally, the investigators grouped all the patients into good pregnancy outcomes group and poor pregnancy outcomes group according to diagnostic criteria, including the incidence of stillbirth and premature birth, to analyze differences of clinical imaging .

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPRES in PE or Epatients diagnosed with posterior reversible encephalopathy syndrome with preeclampsia or eclampsia

Timeline

Start date
2020-10-01
Primary completion
2022-01-31
Completion
2022-01-31
First posted
2021-12-03
Last updated
2022-03-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05143710. Inclusion in this directory is not an endorsement.